GOPI BHAKTA: Open Payments
NPI 1619551108 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 14 payments from 8 companies in 2025. Trend: 2023 $107 · 2024 $158 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $150 |
| Amgen Inc. | 3 | $47 |
| Madrigal Pharmaceuticals | 2 | $40 |
| Novo Nordisk Inc | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
Products named: Veozah, REZDIFFRA, SHINGRIX, JASCAYD, ELIQUIS, Ozempic, The Cologuard Plus Collection Kit, KRYSTEXXA.
Industry payments across TX — which companies pay providers there.
